Title: Non-Alcoholic Steatohepatitis (NASH): An Analysis of Recent Advances in Understanding & Management
1Non-Alcoholic SteatoHepatitis An Analysis of
Disease Prevalence, Drugs in development,
Regulatory guidelines and Market opportunity in
Various Geographies
2Non-Alcoholic Steatohepatitis Global Clinical
Trials Review, H1, 2016
The clinical trial report, Non-Alcoholic
Steatohepatitis Global Clinical Trials Review,
H1, 2016" provides an overview of Non-Alcoholic
Steatohepatitis clinical trials scenario. This
report provides top line data relating to the
clinical trials on Non-Alcoholic Steatohepatitis.
Report includes an overview of trial numbers and
their average enrolment in top countries
conducted across the globe. The report offers
coverage of disease clinical trials by region,
country (G7 E7), phase, trial status, end
points status and sponsor type. Report also
provides prominent drugs for in-progress trials
(based on number of ongoing trials). The report
enhances the decision making capabilities and
helps to create an effective counter strategies
to gain competitive advantage.
www.absolutereports.com
sales_at_absolutereports.com
1 408 520 9750
3Topics Revealed in this Report
- Top Countries Contributing to Clinical Trials in
North America - Top Countries Contributing to Clinical Trials in
Middle East and Africa - Top Five Countries Contributing to Clinical
Trials in Asia-Pacific - Clinical Trials by G7 Countries Proportion of
Non-Alcoholic Steatohepatitis to Gastrointestinal
Clinical Trials - Clinical Trials by E7 Countries Proportion of
Non-Alcoholic Steatohepatitis to Gastrointestinal
Clinical Trials - Top Companies Participating in Non-Alcoholic
Steatohepatitis Therapeutics Clinical Trials
www.absolutereports.com
sales_at_absolutereports.com
1 408 520 9750
4Major/Key players AnalysisThe Research Provides
Company Overview, Business Description, SWOT
Analysis, Major Products/Services, Head Office,
etc. of Following Companies
- Genextra S.p.a.
- Raptor Pharmaceutical Corp.
- Conatus Pharmaceuticals Inc.
- Galmed Pharmaceuticals Ltd.
- DURECT Corporation
www.absolutereports.com
sales_at_absolutereports.com
1 408 520 9750
5Scope of the Report
- The report provides a snapshot of the global
clinical trials landscape - - Report provides top level data related to the
clinical trials by Region, Country (G7 E7),
Trial Status, Trial Phase, Sponsor Type and End
point status - - The report reviews top companies involved and
enlists all trials (Trial title, Phase, and
Status) pertaining to the company - - The report provides all the unaccomplished
trials (Terminated, Suspended and Withdrawn) with
reason for unaccomplishment - - The Report provides enrollment trends for the
past five years - - Report provides latest news for the past three
months
www.absolutereports.com
sales_at_absolutereports.com
1 408 520 9750
6Why one should buy this report?
- Assists in formulating key business strategies
with regards to investment - - Helps in identifying prominent locations for
conducting clinical trials which saves time and
cost - - Provides top level analysis of Global Clinical
Trials Market which helps in identifying key
business opportunities - - Supports understanding of trials count and
enrollment trends by country in global
therapeutics market - - Aids in interpreting the success rates of
clinical trials by providing a comparative
scenario of completed and uncompleted
(terminated, suspended or withdrawn) trials - - Facilitates clinical trial assessment of the
indication on a global, regional and country level
www.absolutereports.com
sales_at_absolutereports.com
1 408 520 9750
7Report Details
- No. Of Pages 205
- No of Tables 23
- No. Figures 24
- Price 2500 (Single User Licence)
www.absolutereports.com
sales_at_absolutereports.com
1 408 520 9750
8Related Reports
- Alcoholic Hepatitis Global Clinical Trials
Review, H1, 2015 - http//www.absolutereports.com/alcoholic-hepatitis
-global-clinical-trials-review-h1-2015-10075347 - Non Alcoholic Fatty Liver Disease (NAFLD) Global
Clinical Trials Review, H1, 2015 - http//www.absolutereports.com/non-alcoholic-fatty
-liver-disease-nafld-global-clinical-trials-review
-h1-2015-10075371
www.absolutereports.com
sales_at_absolutereports.com
1 408 520 9750
9Contact Mr. Ameya Pingaley
www.absolutereports.com
sales_at_absolutereports.com
1 408 520 9750